These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 33919010)

  • 1. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
    Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease.
    Silvestro S; Schepici G; Bramanti P; Mazzon E
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
    Yousaf M; Chang D; Liu Y; Liu T; Zhou X
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
    Tambe SM; Mali S; Amin PD; Oliveira M
    J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.
    Boleti APA; Frihling BEF; E Silva PS; Cardoso PHO; de Moraes LFRN; Rodrigues TAA; Biembengute MEF; Koolen HHF; Migliolo L
    Neurosci Biobehav Rev; 2022 Jan; 132():1214-1228. PubMed ID: 33031814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.
    Silvestro S; Mammana S; Cavalli E; Bramanti P; Mazzon E
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
    Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
    Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current application of cannabidiol (CBD) in the management and treatment of neurological disorders.
    Fiani B; Sarhadi KJ; Soula M; Zafar A; Quadri SA
    Neurol Sci; 2020 Nov; 41(11):3085-3098. PubMed ID: 32556748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
    Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
    Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol - A new fixture in childhood neurology.
    Anderson CL; Carney PR
    Curr Opin Pharmacol; 2021 Dec; 61():142-146. PubMed ID: 34808574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological Aspects of Medical Use of Cannabidiol.
    Mannucci C; Navarra M; Calapai F; Spagnolo EV; Busardò FP; Cas RD; Ippolito FM; Calapai G
    CNS Neurol Disord Drug Targets; 2017; 16(5):541-553. PubMed ID: 28412918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cannabidiol in the treatment of epilepsy.
    Mazurkiewicz-Bełdzińska M; Zawadzka M
    Neurol Neurochir Pol; 2022; 56(1):14-20. PubMed ID: 35211946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol: State of the art and new challenges for therapeutic applications.
    Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
    Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
    Singh K; Bhushan B; Chanchal DK; Sharma SK; Rani K; Yadav MK; Porwal P; Kumar S; Sharma A; Virmani T; Kumar G; Noman AA
    Behav Neurol; 2023; 2023():8825358. PubMed ID: 37868743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
    Kis B; Ifrim FC; Buda V; Avram S; Pavel IZ; Antal D; Paunescu V; Dehelean CA; Ardelean F; Diaconeasa Z; Soica C; Danciu C
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775230
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders.
    de Fátima Dos Santos Sampaio M; de Paiva YB; Sampaio TB; Pereira MG; Coimbra NC
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):574-601. PubMed ID: 38477419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits.
    Jha SK; Nelson VK; Suryadevara PR; Panda SP; Pullaiah CP; Nuli MV; Kamal M; Imran M; Ausali S; Abomughaid MM; Srivastava R; Deka R; Pritam P; Gupta N; Shyam H; Singh IK; Pandey BW; Dewanjee S; Jha NK; Jafari SM
    Ageing Res Rev; 2024 Sep; 100():102386. PubMed ID: 38969143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.